BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
2508346
Number of visits today
15
Number of downloads
1690162
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Wan Y, Yan C, Gao H, Liu T. Small-molecule PROTACs: novel agents for cancer therapy. Future Medicinal Chemistry 2020;12:915-38. [DOI: 10.4155/fmc-2019-0340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ma S, Ji J, Tong Y, Zhu Y, Dou J, Zhang X, Xu S, Zhu T, Xu X, You Q, Jiang Z. Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 T Tavares M, Shen S. Recent innovative advances in the discovery of selective HDAC6 inhibitors. Future Med Chem 2021;13:1017-9. [PMID: 33906379 DOI: 10.4155/fmc-2021-0040] [Reference Citation Analysis]
3 Zhong Y, Chi F, Wu H, Liu Y, Xie Z, Huang W, Shi W, Qian H. Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond. European Journal of Medicinal Chemistry 2022;231:114142. [DOI: 10.1016/j.ejmech.2022.114142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang Y, Deng S, Xu J. Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets. Cancer Biol Med 2020;17:583-98. [PMID: 32944392 DOI: 10.20892/j.issn.2095-3941.2020.0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nussinov R, Zhang M, Maloney R, Tsai CJ, Yavuz BR, Tuncbag N, Jang H. Mechanism of activation and the rewired network: New drug design concepts. Med Res Rev 2021. [PMID: 34693559 DOI: 10.1002/med.21863] [Reference Citation Analysis]
6 Wall H. Targeted protein degradation: a new paradigm in medicinal chemistry. Future Med Chem 2022;:115-7. [PMID: 35080920 DOI: 10.4155/fmc-2021-0330] [Reference Citation Analysis]
7 Liao J, Nie X, Unarta IC, Ericksen SS, Tang W. In Silico Modeling and Scoring of PROTAC-Mediated Ternary Complex Poses. J Med Chem 2022. [PMID: 35412837 DOI: 10.1021/acs.jmedchem.1c02155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345